Literature DB >> 8615332

Effect of weight on cardiovascular disease.

W B Kannel1, R B D'Agostino, J L Cobb.   

Abstract

Involuntary weight gains worsen all elements of the cardiovascular risk profile, including dyslipidemia, hypertension, insulin-resistant glucose intolerance, left-ventricular hypertrophy, hyperuricemia, and elevated fibrinogen. On the basis of data from the Framingham Heart Study and from other studies, it can be concluded that the degree of overweight is related to the rate of development of cardiovascular disease. After 26 y of follow-up in the Framingham study, each SD increment in relative weight was associated with 15% and 22% increases in cardiovascular events in men and women, respectively. Avoidance of weight gain after the age of 25 y is advisable to reduce cardiovascular mortality. There is a great potential benefit to weight loss, suggesting that weight control as a means for preventing and lessening cardiovascular disease become a national health priority. The optimal weight for avoidance of cardiovascular disease and prolonging life corresponds to a body mass index of 22.6 for men and 21.1 for women.

Entities:  

Mesh:

Year:  1996        PMID: 8615332     DOI: 10.1093/ajcn/87.6.1602

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  37 in total

1.  Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors:  J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

2.  Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers.

Authors:  Tao Liu; Sean P David; Rachel F Tyndale; Hui Wang; Xue-Qing Yu; Wei Chen; Qian Zhou; Wei-Qing Chen
Journal:  Ann Behav Med       Date:  2012-04

3.  Western-style diet modulates contractile responses to phenylephrine differently in mesenteric arteries from senescence-accelerated prone (SAMP8) and resistant (SAMR1) mice.

Authors:  Francesc Jiménez-Altayó; Yara Onetti; Magda Heras; Ana P Dantas; Elisabet Vila
Journal:  Age (Dordr)       Date:  2012-07-10

4.  Is the onset of obesity the same as aging?

Authors:  Anne B Newman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-16       Impact factor: 11.205

5.  Body composition assessment and coronary heart disease risk factors among college students of three ethnic groups.

Authors:  Samer Koutoubi; Fatma G Huffman
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

6.  Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice.

Authors:  Angela Burgess; Ming Li; Luca Vanella; Dong Hyun Kim; Rita Rezzani; Luigi Rodella; Komal Sodhi; Martina Canestraro; Pavel Martasek; Stephen J Peterson; Attallah Kappas; Nader G Abraham
Journal:  Hypertension       Date:  2010-11-01       Impact factor: 10.190

7.  Effects of isolated obesity on systolic and diastolic left ventricular function.

Authors:  M Pascual; D A Pascual; F Soria; T Vicente; A M Hernández; F J Tébar; M Valdés
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

8.  Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children.

Authors:  S Murugesan; M Ulloa-Martínez; H Martínez-Rojano; F M Galván-Rodríguez; C Miranda-Brito; M C Romano; A Piña-Escobedo; M L Pizano-Zárate; C Hoyo-Vadillo; J García-Mena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-12       Impact factor: 3.267

9.  Effects of a weight-reduction program with orlistat on serum leptin levels in obese women: A 12-week, randomized, placebo-controlled study.

Authors:  Oguz Ozcelik; Halil Dogan; Haluk Kelestimur
Journal:  Curr Ther Res Clin Exp       Date:  2004-03

10.  Design considerations and rationale of a multi-center trial to sustain weight loss: the Weight Loss Maintenance Trial.

Authors:  Phillip Brantley; Lawrence Appel; Jack Hollis; Victor Stevens; Jamy Ard; Catherine Champagne; Patricia Elmer; David Harsha; Valerie Myers; Michael Proschan; Vollmer William; Laura Svetkey
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.